Bayer Cropscience
Stock Snapshot
Price Performance
Vista Outlook
Basis of our Recommendation
Bayer CropScience's management has articulated a clear strategy focused on innovation and digital integration to enhance productivity in the evolving agricultural landscape. Their commitment to leveraging government initiatives, such as the Digital Agriculture Mission, positions the company favorably for revenue growth, particularly as they upgrade manufacturing capabilities and explore new product compounds. Vista's financial outlook reflects stable revenue growth aligned with historical performance, supported by improving margins due to enhanced operational efficiencies. The company's conservatively financed balance sheet, with low leverage, further underpins its financial stability. However, the cautious investor sentiment and external risks, including climate volatility and regulatory changes, present challenges. The fertilizers and pesticides industry is currently expanding, driven by rising chemical prices and improving pricing power, which could benefit Bayer. Over the next 12-24 months, key opportunities include the adoption of digital farming technologies and sustainable practices, while headwinds may arise from geopolitical tensions and market competition. Overall, Bayer's strategic focus and the favorable industry backdrop support Vista's forecast, although vigilance is warranted regarding external risks
Why We Like This Stock
- Management's focus on innovation and digital integration enhances productivity and aligns with government initiatives
- Improving margins and a conservatively financed balance sheet support financial stability and profitability
- The expanding fertilizers and pesticides industry, driven by rising chemical prices, presents growth opportunities
Things To Watch Out For
- Cautious investor sentiment may limit short-term price appreciation
- External risks related to climate volatility and regulatory changes could impact operational performance
- Intense competition within the fragmented market may pressure market share and pricing strategies
Key Parameters
Financial Snapshot
View Technicals Analysis →| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 5,106 | 5,473 | 5,675 | 5,622 | 5,769 |
| Profit Before Tax (Cr.) | 943 | 708 | 855 | 892 | 904 |
| PBT Margin | 18.5% | 12.9% | 15.1% | 15.9% | 15.7% |
| Net Profit (Cr.) | 744 | 557 | 690 | 723 | 733 |
| Earnings Per Share | 165.8 | 124.1 | 153.7 | 161.1 | 163.3 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| HSBC | ▲ Buy | 5,400 | 07-Aug-2026 |
| Kotak Securities | ► Add | 4,820 | 19-Jun-2026 |
Company Overview
Show Company Profile
Bayer CropScience Limited, together with its subsidiaries, engages in the agriculture business in India, Germany, Bangladesh, and internationally. The company manufactures, sells, and distributes agrochemical products, including insecticides, fungicides, herbicides, seed treatment solutions, and biologicals; produces, sells, and distributes hybrid corn seeds, as well as rice, fruits, and vegetables; and integrates digital farming solutions, such as remote sensing, artificial intelligence, IoT, drones, and data analytics. It also offers medicines for various therapeutic areas comprising cardiology, diabetes, kidney health, women's health, oncology, ophthalmology, and radiology; and over-the-counter products, including analgesics, nutrition, allergy, dermatology, and digestives. Bayer CropScience Limited was founded in 1896 and is based in Thane, India.